Lupin aims to launch new products across globe in current fiscal
15th Jul 2019

Lupin is aiming to launch its first biosimilar product and commercialize its first inhalation product in the US in the current fiscal. The new launches across the globe would help it achieve sustainable growth.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.